 Global Small Molecule Drugs CDMO Services Market Growth (Status and Outlook) 2026-2032
The global Small Molecule Drugs CDMO Services market size is predicted to grow from US$ 96620 million in 2025 to US$ 159560 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 20... もっと見る
図表リストList of TablesTable 1. Small Molecule Drugs CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. Small Molecule Drugs CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Molecular Drug Intermediates Table 4. Major Players of API Table 5. Major Players of Prepared Products Table 6. Small Molecule Drugs CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 7. Global Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 8. Global Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Table 9. Small Molecule Drugs CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 10. Global Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 11. Global Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Table 12. Global Small Molecule Drugs CDMO Services Revenue by Player (2021-2026) & ($ millions) Table 13. Global Small Molecule Drugs CDMO Services Revenue Market Share by Player (2021-2026) Table 14. Small Molecule Drugs CDMO Services Key Players Head office and Products Offered Table 15. Small Molecule Drugs CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) & ($ millions) Table 19. Global Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Table 20. Global Small Molecule Drugs CDMO Services Revenue by Country/Region (2021-2026) & ($ millions) Table 21. Global Small Molecule Drugs CDMO Services Revenue Market Share by Country/Region (2021-2026) Table 22. Americas Small Molecule Drugs CDMO Services Market Size by Country (2021-2026) & ($ millions) Table 23. Americas Small Molecule Drugs CDMO Services Market Size Market Share by Country (2021-2026) Table 24. Americas Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 25. Americas Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Table 26. Americas Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 27. Americas Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Table 28. APAC Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) & ($ millions) Table 29. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Table 30. APAC Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 31. APAC Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 32. Europe Small Molecule Drugs CDMO Services Market Size by Country (2021-2026) & ($ millions) Table 33. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Country (2021-2026) Table 34. Europe Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 35. Europe Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 36. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) & ($ millions) Table 37. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 38. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Small Molecule Drugs CDMO Services Table 40. Key Market Challenges & Risks of Small Molecule Drugs CDMO Services Table 41. Key Industry Trends of Small Molecule Drugs CDMO Services Table 42. Global Small Molecule Drugs CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions) Table 43. Global Small Molecule Drugs CDMO Services Market Size Market Share Forecast by Region (2027-2032) Table 44. Global Small Molecule Drugs CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions) Table 45. Global Small Molecule Drugs CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions) Table 46. Catalent Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 47. Catalent Small Molecule Drugs CDMO Services Product Offered Table 48. Catalent Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 49. Catalent Main Business Table 50. Catalent Latest Developments Table 51. Thermo Fisher Scientific Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 52. Thermo Fisher Scientific Small Molecule Drugs CDMO Services Product Offered Table 53. Thermo Fisher Scientific Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 54. Thermo Fisher Scientific Main Business Table 55. Thermo Fisher Scientific Latest Developments Table 56. Lonza Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 57. Lonza Small Molecule Drugs CDMO Services Product Offered Table 58. Lonza Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 59. Lonza Main Business Table 60. Lonza Latest Developments Table 61. Siegfried Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 62. Siegfried Small Molecule Drugs CDMO Services Product Offered Table 63. Siegfried Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 64. Siegfried Main Business Table 65. Siegfried Latest Developments Table 66. Recipharm Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 67. Recipharm Small Molecule Drugs CDMO Services Product Offered Table 68. Recipharm Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 69. Recipharm Main Business Table 70. Recipharm Latest Developments Table 71. Boehringer Ingelheim Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 72. Boehringer Ingelheim Small Molecule Drugs CDMO Services Product Offered Table 73. Boehringer Ingelheim Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 74. Boehringer Ingelheim Main Business Table 75. Boehringer Ingelheim Latest Developments Table 76. WuXi AppTech Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 77. WuXi AppTech Small Molecule Drugs CDMO Services Product Offered Table 78. WuXi AppTech Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 79. WuXi AppTech Main Business Table 80. WuXi AppTech Latest Developments Table 81. WuXi Biologics Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 82. WuXi Biologics Small Molecule Drugs CDMO Services Product Offered Table 83. WuXi Biologics Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 84. WuXi Biologics Main Business Table 85. WuXi Biologics Latest Developments Table 86. Fareva Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 87. Fareva Small Molecule Drugs CDMO Services Product Offered Table 88. Fareva Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 89. Fareva Main Business Table 90. Fareva Latest Developments Table 91. Samsung Biologics Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 92. Samsung Biologics Small Molecule Drugs CDMO Services Product Offered Table 93. Samsung Biologics Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 94. Samsung Biologics Main Business Table 95. Samsung Biologics Latest Developments Table 96. Aenova Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 97. Aenova Small Molecule Drugs CDMO Services Product Offered Table 98. Aenova Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 99. Aenova Main Business Table 100. Aenova Latest Developments Table 101. Delpharm Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 102. Delpharm Small Molecule Drugs CDMO Services Product Offered Table 103. Delpharm Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 104. Delpharm Main Business Table 105. Delpharm Latest Developments Table 106. Strides Pharma Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 107. Strides Pharma Small Molecule Drugs CDMO Services Product Offered Table 108. Strides Pharma Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 109. Strides Pharma Main Business Table 110. Strides Pharma Latest Developments Table 111. Piramal Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 112. Piramal Small Molecule Drugs CDMO Services Product Offered Table 113. Piramal Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 114. Piramal Main Business Table 115. Piramal Latest Developments Table 116. Famar Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 117. Famar Small Molecule Drugs CDMO Services Product Offered Table 118. Famar Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 119. Famar Main Business Table 120. Famar Latest Developments Table 121. Curia Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 122. Curia Small Molecule Drugs CDMO Services Product Offered Table 123. Curia Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 124. Curia Main Business Table 125. Curia Latest Developments Table 126. Jubilant Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 127. Jubilant Small Molecule Drugs CDMO Services Product Offered Table 128. Jubilant Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 129. Jubilant Main Business Table 130. Jubilant Latest Developments Table 131. Vetter Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 132. Vetter Small Molecule Drugs CDMO Services Product Offered Table 133. Vetter Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 134. Vetter Main Business Table 135. Vetter Latest Developments Table 136. AGC Pharma Chemicals Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 137. AGC Pharma Chemicals Small Molecule Drugs CDMO Services Product Offered Table 138. AGC Pharma Chemicals Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 139. AGC Pharma Chemicals Main Business Table 140. AGC Pharma Chemicals Latest Developments Table 141. Asymchem Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 142. Asymchem Small Molecule Drugs CDMO Services Product Offered Table 143. Asymchem Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 144. Asymchem Main Business Table 145. Asymchem Latest Developments Table 146. Porton Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 147. Porton Small Molecule Drugs CDMO Services Product Offered Table 148. Porton Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 149. Porton Main Business Table 150. Porton Latest Developments Table 151. Eurofins Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 152. Eurofins Small Molecule Drugs CDMO Services Product Offered Table 153. Eurofins Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 154. Eurofins Main Business Table 155. Eurofins Latest Developments Table 156. Ascendia Pharmaceuticals Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 157. Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Product Offered Table 158. Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 159. Ascendia Pharmaceuticals Main Business Table 160. Ascendia Pharmaceuticals Latest Developments Table 161. Ardena Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 162. Ardena Small Molecule Drugs CDMO Services Product Offered Table 163. Ardena Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 164. Ardena Main Business Table 165. Ardena Latest Developments Table 166. CPL Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 167. CPL Small Molecule Drugs CDMO Services Product Offered Table 168. CPL Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 169. CPL Main Business Table 170. CPL Latest Developments Table 171. UPM Pharmaceuticals Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 172. UPM Pharmaceuticals Small Molecule Drugs CDMO Services Product Offered Table 173. UPM Pharmaceuticals Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 174. UPM Pharmaceuticals Main Business Table 175. UPM Pharmaceuticals Latest Developments Table 176. FUJIFILM Diosynth Biotechnologies Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 177. FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Product Offered Table 178. FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 179. FUJIFILM Diosynth Biotechnologies Main Business Table 180. FUJIFILM Diosynth Biotechnologies Latest Developments Table 181. Groupe Parima Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 182. Groupe Parima Small Molecule Drugs CDMO Services Product Offered Table 183. Groupe Parima Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 184. Groupe Parima Main Business Table 185. Groupe Parima Latest Developments Table 186. TBD Pharmatech Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 187. TBD Pharmatech Small Molecule Drugs CDMO Services Product Offered Table 188. TBD Pharmatech Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 189. TBD Pharmatech Main Business Table 190. TBD Pharmatech Latest Developments Table 191. Avid Bioservices Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 192. Avid Bioservices Small Molecule Drugs CDMO Services Product Offered Table 193. Avid Bioservices Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 194. Avid Bioservices Main Business Table 195. Avid Bioservices Latest Developments Table 196. NextPharma Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 197. NextPharma Small Molecule Drugs CDMO Services Product Offered Table 198. NextPharma Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 199. NextPharma Main Business Table 200. NextPharma Latest Developments Table 201. Alcami Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 202. Alcami Small Molecule Drugs CDMO Services Product Offered Table 203. Alcami Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 204. Alcami Main Business Table 205. Alcami Latest Developments Table 206. Societal CDMO Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 207. Societal CDMO Small Molecule Drugs CDMO Services Product Offered Table 208. Societal CDMO Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 209. Societal CDMO Main Business Table 210. Societal CDMO Latest Developments Table 211. MedPharm Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 212. MedPharm Small Molecule Drugs CDMO Services Product Offered Table 213. MedPharm Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 214. MedPharm Main Business Table 215. MedPharm Latest Developments Table 216. Euroapi Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 217. Euroapi Small Molecule Drugs CDMO Services Product Offered Table 218. Euroapi Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 219. Euroapi Main Business Table 220. Euroapi Latest Developments Table 221. BioVectra Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 222. BioVectra Small Molecule Drugs CDMO Services Product Offered Table 223. BioVectra Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 224. BioVectra Main Business Table 225. BioVectra Latest Developments Table 226. Pfizer CentreOne Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 227. Pfizer CentreOne Small Molecule Drugs CDMO Services Product Offered Table 228. Pfizer CentreOne Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 229. Pfizer CentreOne Main Business Table 230. Pfizer CentreOne Latest Developments Table 231. Fermion Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 232. Fermion Small Molecule Drugs CDMO Services Product Offered Table 233. Fermion Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 234. Fermion Main Business Table 235. Fermion Latest Developments Table 236. Lundbeck Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 237. Lundbeck Small Molecule Drugs CDMO Services Product Offered Table 238. Lundbeck Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 239. Lundbeck Main Business Table 240. Lundbeck Latest Developments List of Figures Figure 1. Small Molecule Drugs CDMO Services Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Small Molecule Drugs CDMO Services Market Size Growth Rate (2021-2032) ($ millions) Figure 6. Small Molecule Drugs CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. Small Molecule Drugs CDMO Services Sales Market Share by Country/Region (2025) Figure 8. Small Molecule Drugs CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global Small Molecule Drugs CDMO Services Market Size Market Share by Type in 2025 Figure 10. Small Molecule Drugs CDMO Services in Clinical Figure 11. Global Small Molecule Drugs CDMO Services Market: Clinical (2021-2026) & ($ millions) Figure 12. Small Molecule Drugs CDMO Services in Commercial Figure 13. Global Small Molecule Drugs CDMO Services Market: Commercial (2021-2026) & ($ millions) Figure 14. Global Small Molecule Drugs CDMO Services Market Size Market Share by Application in 2025 Figure 15. Global Small Molecule Drugs CDMO Services Revenue Market Share by Player in 2025 Figure 16. Global Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Figure 17. Americas Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 18. APAC Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 19. Europe Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 20. Middle East & Africa Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 21. Americas Small Molecule Drugs CDMO Services Value Market Share by Country in 2025 Figure 22. United States Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 23. Canada Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 24. Mexico Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 25. Brazil Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 26. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Region in 2025 Figure 27. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Figure 28. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Figure 29. China Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 30. Japan Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 31. South Korea Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 32. Southeast Asia Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 33. India Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 34. Australia Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 35. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Country in 2025 Figure 36. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Figure 37. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Figure 38. Germany Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 39. France Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 40. UK Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 41. Italy Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 42. Russia Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 43. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Figure 44. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Figure 45. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Figure 46. Egypt Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 47. South Africa Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 48. Israel Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 49. Turkey Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 50. GCC Countries Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 51. Americas Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 52. APAC Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 53. Europe Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 54. Middle East & Africa Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 55. United States Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 56. Canada Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 57. Mexico Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 58. Brazil Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 59. China Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 60. Japan Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 61. Korea Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 62. Southeast Asia Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 63. India Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 64. Australia Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 65. Germany Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 66. France Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 67. UK Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 68. Italy Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 69. Russia Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 70. Egypt Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 71. South Africa Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 72. Israel Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 73. Turkey Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 74. Global Small Molecule Drugs CDMO Services Market Size Market Share Forecast by Type (2027-2032) Figure 75. Global Small Molecule Drugs CDMO Services Market Size Market Share Forecast by Application (2027-2032) Figure 76. GCC Countries Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions)
SummaryThe global Small Molecule Drugs CDMO Services market size is predicted to grow from US$ 96620 million in 2025 to US$ 159560 million in 2032; it is expected to grow at a CAGR of 7.6% from 2026 to 2032.Small molecule drugs CDMO services refer to end-to-end contract development and manufacturing solutions provided by third-party organizations to support pharmaceutical companies in the development, scale-up, and commercialization of small molecule drugs. These services typically include process development, API and intermediate synthesis under GMP conditions, formulation development, analytical testing, clinical trial material supply, stability studies, and global regulatory support. CDMO partners help reduce development timelines, manage costs, and provide flexible manufacturing capacity, especially for high-potency APIs and complex formulations. As small molecule drugs continue to dominate global therapeutics, CDMO services are becoming integral to efficient and agile drug development strategies. Global key Small Molecule Drugs CDMO Services players cover Catalent, Thermo Fisher Scientific, Lonza, Siegfried, Recipharm, etc. Report Scope LPI (LP Information)' newest research report, the “Small Molecule Drugs CDMO Services Industry Forecast” looks at past sales and reviews total world Small Molecule Drugs CDMO Services sales in 2025, providing a comprehensive analysis by region and market sector of projected Small Molecule Drugs CDMO Services sales for 2026 through 2032. With Small Molecule Drugs CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule Drugs CDMO Services industry. This Insight Report provides a comprehensive analysis of the global Small Molecule Drugs CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Small Molecule Drugs CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule Drugs CDMO Services market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule Drugs CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule Drugs CDMO Services. This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule Drugs CDMO Services market by product type, application, key players and key regions and countries. Market Segmentation Segmentation by Type: Molecular Drug Intermediates API Prepared Products Segmentation by Application: Clinical Commercial This report also splits the market by region: Americas United States Canada Mexico Brazil APAC China Japan Korea Southeast Asia India Australia Europe Germany France UK Italy Russia Middle East & Africa Egypt South Africa Israel Turkey GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration. Catalent Thermo Fisher Scientific Lonza Siegfried Recipharm Boehringer Ingelheim WuXi AppTech WuXi Biologics Fareva Samsung Biologics Aenova Delpharm Strides Pharma Piramal Famar Curia Jubilant Vetter AGC Pharma Chemicals Asymchem Porton Eurofins Ascendia Pharmaceuticals Ardena CPL UPM Pharmaceuticals FUJIFILM Diosynth Biotechnologies Groupe Parima TBD Pharmatech Avid Bioservices NextPharma Alcami Societal CDMO MedPharm Euroapi BioVectra Pfizer CentreOne Fermion Lundbeck Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Small Molecule Drugs CDMO Services Market Size (2021-2032) 2.1.2 Small Molecule Drugs CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) 2.1.3 World Current & Future Analysis for Small Molecule Drugs CDMO Services by Country/Region (2021, 2025 & 2032) 2.2 Small Molecule Drugs CDMO Services Segment by Type 2.2.1 Molecular Drug Intermediates 2.2.2 API 2.2.3 Prepared Products 2.2.4 Small Molecule Drugs CDMO Services Market Size by Type 2.2.4.1 Small Molecule Drugs CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) 2.2.4.2 Global Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) 2.3 Small Molecule Drugs CDMO Services Segment by Application 2.3.1 Clinical 2.3.2 Commercial 2.3.3 Small Molecule Drugs CDMO Services Market Size by Application 2.3.3.1 Small Molecule Drugs CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) 2.3.3.2 Global Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) 3 Small Molecule Drugs CDMO Services Market Size by Player 3.1 Small Molecule Drugs CDMO Services Market Size Market Share by Player 3.1.1 Global Small Molecule Drugs CDMO Services Revenue by Player (2021-2026) 3.1.2 Global Small Molecule Drugs CDMO Services Revenue Market Share by Player (2021-2026) 3.2 Global Small Molecule Drugs CDMO Services Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Small Molecule Drugs CDMO Services by Region 4.1 Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) 4.2 Global Small Molecule Drugs CDMO Services Annual Revenue by Country/Region (2021-2026) 4.3 Americas Small Molecule Drugs CDMO Services Market Size Growth (2021-2026) 4.4 APAC Small Molecule Drugs CDMO Services Market Size Growth (2021-2026) 4.5 Europe Small Molecule Drugs CDMO Services Market Size Growth (2021-2026) 4.6 Middle East & Africa Small Molecule Drugs CDMO Services Market Size Growth (2021-2026) 5 Americas 5.1 Americas Small Molecule Drugs CDMO Services Market Size by Country (2021-2026) 5.2 Americas Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) 5.3 Americas Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) 6.2 APAC Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) 6.3 APAC Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Small Molecule Drugs CDMO Services Market Size by Country (2021-2026) 7.2 Europe Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) 7.3 Europe Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Small Molecule Drugs CDMO Services by Region (2021-2026) 8.2 Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) 8.3 Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Small Molecule Drugs CDMO Services Market Forecast 10.1 Global Small Molecule Drugs CDMO Services Forecast by Region (2027-2032) 10.1.1 Global Small Molecule Drugs CDMO Services Forecast by Region (2027-2032) 10.1.2 Americas Small Molecule Drugs CDMO Services Forecast 10.1.3 APAC Small Molecule Drugs CDMO Services Forecast 10.1.4 Europe Small Molecule Drugs CDMO Services Forecast 10.1.5 Middle East & Africa Small Molecule Drugs CDMO Services Forecast 10.2 Americas Small Molecule Drugs CDMO Services Forecast by Country (2027-2032) 10.2.1 United States Market Small Molecule Drugs CDMO Services Forecast 10.2.2 Canada Market Small Molecule Drugs CDMO Services Forecast 10.2.3 Mexico Market Small Molecule Drugs CDMO Services Forecast 10.2.4 Brazil Market Small Molecule Drugs CDMO Services Forecast 10.3 APAC Small Molecule Drugs CDMO Services Forecast by Region (2027-2032) 10.3.1 China Small Molecule Drugs CDMO Services Market Forecast 10.3.2 Japan Market Small Molecule Drugs CDMO Services Forecast 10.3.3 Korea Market Small Molecule Drugs CDMO Services Forecast 10.3.4 Southeast Asia Market Small Molecule Drugs CDMO Services Forecast 10.3.5 India Market Small Molecule Drugs CDMO Services Forecast 10.3.6 Australia Market Small Molecule Drugs CDMO Services Forecast 10.4 Europe Small Molecule Drugs CDMO Services Forecast by Country (2027-2032) 10.4.1 Germany Market Small Molecule Drugs CDMO Services Forecast 10.4.2 France Market Small Molecule Drugs CDMO Services Forecast 10.4.3 UK Market Small Molecule Drugs CDMO Services Forecast 10.4.4 Italy Market Small Molecule Drugs CDMO Services Forecast 10.4.5 Russia Market Small Molecule Drugs CDMO Services Forecast 10.5 Middle East & Africa Small Molecule Drugs CDMO Services Forecast by Region (2027-2032) 10.5.1 Egypt Market Small Molecule Drugs CDMO Services Forecast 10.5.2 South Africa Market Small Molecule Drugs CDMO Services Forecast 10.5.3 Israel Market Small Molecule Drugs CDMO Services Forecast 10.5.4 Turkey Market Small Molecule Drugs CDMO Services Forecast 10.6 Global Small Molecule Drugs CDMO Services Forecast by Type (2027-2032) 10.7 Global Small Molecule Drugs CDMO Services Forecast by Application (2027-2032) 10.7.1 GCC Countries Market Small Molecule Drugs CDMO Services Forecast 11 Key Players Analysis 11.1 Catalent 11.1.1 Catalent Company Information 11.1.2 Catalent Small Molecule Drugs CDMO Services Product Offered 11.1.3 Catalent Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.1.4 Catalent Main Business Overview 11.1.5 Catalent Latest Developments 11.2 Thermo Fisher Scientific 11.2.1 Thermo Fisher Scientific Company Information 11.2.2 Thermo Fisher Scientific Small Molecule Drugs CDMO Services Product Offered 11.2.3 Thermo Fisher Scientific Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.2.4 Thermo Fisher Scientific Main Business Overview 11.2.5 Thermo Fisher Scientific Latest Developments 11.3 Lonza 11.3.1 Lonza Company Information 11.3.2 Lonza Small Molecule Drugs CDMO Services Product Offered 11.3.3 Lonza Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.3.4 Lonza Main Business Overview 11.3.5 Lonza Latest Developments 11.4 Siegfried 11.4.1 Siegfried Company Information 11.4.2 Siegfried Small Molecule Drugs CDMO Services Product Offered 11.4.3 Siegfried Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.4.4 Siegfried Main Business Overview 11.4.5 Siegfried Latest Developments 11.5 Recipharm 11.5.1 Recipharm Company Information 11.5.2 Recipharm Small Molecule Drugs CDMO Services Product Offered 11.5.3 Recipharm Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.5.4 Recipharm Main Business Overview 11.5.5 Recipharm Latest Developments 11.6 Boehringer Ingelheim 11.6.1 Boehringer Ingelheim Company Information 11.6.2 Boehringer Ingelheim Small Molecule Drugs CDMO Services Product Offered 11.6.3 Boehringer Ingelheim Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.6.4 Boehringer Ingelheim Main Business Overview 11.6.5 Boehringer Ingelheim Latest Developments 11.7 WuXi AppTech 11.7.1 WuXi AppTech Company Information 11.7.2 WuXi AppTech Small Molecule Drugs CDMO Services Product Offered 11.7.3 WuXi AppTech Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.7.4 WuXi AppTech Main Business Overview 11.7.5 WuXi AppTech Latest Developments 11.8 WuXi Biologics 11.8.1 WuXi Biologics Company Information 11.8.2 WuXi Biologics Small Molecule Drugs CDMO Services Product Offered 11.8.3 WuXi Biologics Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.8.4 WuXi Biologics Main Business Overview 11.8.5 WuXi Biologics Latest Developments 11.9 Fareva 11.9.1 Fareva Company Information 11.9.2 Fareva Small Molecule Drugs CDMO Services Product Offered 11.9.3 Fareva Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.9.4 Fareva Main Business Overview 11.9.5 Fareva Latest Developments 11.10 Samsung Biologics 11.10.1 Samsung Biologics Company Information 11.10.2 Samsung Biologics Small Molecule Drugs CDMO Services Product Offered 11.10.3 Samsung Biologics Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.10.4 Samsung Biologics Main Business Overview 11.10.5 Samsung Biologics Latest Developments 11.11 Aenova 11.11.1 Aenova Company Information 11.11.2 Aenova Small Molecule Drugs CDMO Services Product Offered 11.11.3 Aenova Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.11.4 Aenova Main Business Overview 11.11.5 Aenova Latest Developments 11.12 Delpharm 11.12.1 Delpharm Company Information 11.12.2 Delpharm Small Molecule Drugs CDMO Services Product Offered 11.12.3 Delpharm Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.12.4 Delpharm Main Business Overview 11.12.5 Delpharm Latest Developments 11.13 Strides Pharma 11.13.1 Strides Pharma Company Information 11.13.2 Strides Pharma Small Molecule Drugs CDMO Services Product Offered 11.13.3 Strides Pharma Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.13.4 Strides Pharma Main Business Overview 11.13.5 Strides Pharma Latest Developments 11.14 Piramal 11.14.1 Piramal Company Information 11.14.2 Piramal Small Molecule Drugs CDMO Services Product Offered 11.14.3 Piramal Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.14.4 Piramal Main Business Overview 11.14.5 Piramal Latest Developments 11.15 Famar 11.15.1 Famar Company Information 11.15.2 Famar Small Molecule Drugs CDMO Services Product Offered 11.15.3 Famar Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.15.4 Famar Main Business Overview 11.15.5 Famar Latest Developments 11.16 Curia 11.16.1 Curia Company Information 11.16.2 Curia Small Molecule Drugs CDMO Services Product Offered 11.16.3 Curia Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.16.4 Curia Main Business Overview 11.16.5 Curia Latest Developments 11.17 Jubilant 11.17.1 Jubilant Company Information 11.17.2 Jubilant Small Molecule Drugs CDMO Services Product Offered 11.17.3 Jubilant Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.17.4 Jubilant Main Business Overview 11.17.5 Jubilant Latest Developments 11.18 Vetter 11.18.1 Vetter Company Information 11.18.2 Vetter Small Molecule Drugs CDMO Services Product Offered 11.18.3 Vetter Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.18.4 Vetter Main Business Overview 11.18.5 Vetter Latest Developments 11.19 AGC Pharma Chemicals 11.19.1 AGC Pharma Chemicals Company Information 11.19.2 AGC Pharma Chemicals Small Molecule Drugs CDMO Services Product Offered 11.19.3 AGC Pharma Chemicals Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.19.4 AGC Pharma Chemicals Main Business Overview 11.19.5 AGC Pharma Chemicals Latest Developments 11.20 Asymchem 11.20.1 Asymchem Company Information 11.20.2 Asymchem Small Molecule Drugs CDMO Services Product Offered 11.20.3 Asymchem Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.20.4 Asymchem Main Business Overview 11.20.5 Asymchem Latest Developments 11.21 Porton 11.21.1 Porton Company Information 11.21.2 Porton Small Molecule Drugs CDMO Services Product Offered 11.21.3 Porton Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.21.4 Porton Main Business Overview 11.21.5 Porton Latest Developments 11.22 Eurofins 11.22.1 Eurofins Company Information 11.22.2 Eurofins Small Molecule Drugs CDMO Services Product Offered 11.22.3 Eurofins Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.22.4 Eurofins Main Business Overview 11.22.5 Eurofins Latest Developments 11.23 Ascendia Pharmaceuticals 11.23.1 Ascendia Pharmaceuticals Company Information 11.23.2 Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Product Offered 11.23.3 Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.23.4 Ascendia Pharmaceuticals Main Business Overview 11.23.5 Ascendia Pharmaceuticals Latest Developments 11.24 Ardena 11.24.1 Ardena Company Information 11.24.2 Ardena Small Molecule Drugs CDMO Services Product Offered 11.24.3 Ardena Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.24.4 Ardena Main Business Overview 11.24.5 Ardena Latest Developments 11.25 CPL 11.25.1 CPL Company Information 11.25.2 CPL Small Molecule Drugs CDMO Services Product Offered 11.25.3 CPL Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.25.4 CPL Main Business Overview 11.25.5 CPL Latest Developments 11.26 UPM Pharmaceuticals 11.26.1 UPM Pharmaceuticals Company Information 11.26.2 UPM Pharmaceuticals Small Molecule Drugs CDMO Services Product Offered 11.26.3 UPM Pharmaceuticals Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.26.4 UPM Pharmaceuticals Main Business Overview 11.26.5 UPM Pharmaceuticals Latest Developments 11.27 FUJIFILM Diosynth Biotechnologies 11.27.1 FUJIFILM Diosynth Biotechnologies Company Information 11.27.2 FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Product Offered 11.27.3 FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.27.4 FUJIFILM Diosynth Biotechnologies Main Business Overview 11.27.5 FUJIFILM Diosynth Biotechnologies Latest Developments 11.28 Groupe Parima 11.28.1 Groupe Parima Company Information 11.28.2 Groupe Parima Small Molecule Drugs CDMO Services Product Offered 11.28.3 Groupe Parima Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.28.4 Groupe Parima Main Business Overview 11.28.5 Groupe Parima Latest Developments 11.29 TBD Pharmatech 11.29.1 TBD Pharmatech Company Information 11.29.2 TBD Pharmatech Small Molecule Drugs CDMO Services Product Offered 11.29.3 TBD Pharmatech Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.29.4 TBD Pharmatech Main Business Overview 11.29.5 TBD Pharmatech Latest Developments 11.30 Avid Bioservices 11.30.1 Avid Bioservices Company Information 11.30.2 Avid Bioservices Small Molecule Drugs CDMO Services Product Offered 11.30.3 Avid Bioservices Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.30.4 Avid Bioservices Main Business Overview 11.30.5 Avid Bioservices Latest Developments 11.31 NextPharma 11.31.1 NextPharma Company Information 11.31.2 NextPharma Small Molecule Drugs CDMO Services Product Offered 11.31.3 NextPharma Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.31.4 NextPharma Main Business Overview 11.31.5 NextPharma Latest Developments 11.32 Alcami 11.32.1 Alcami Company Information 11.32.2 Alcami Small Molecule Drugs CDMO Services Product Offered 11.32.3 Alcami Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.32.4 Alcami Main Business Overview 11.32.5 Alcami Latest Developments 11.33 Societal CDMO 11.33.1 Societal CDMO Company Information 11.33.2 Societal CDMO Small Molecule Drugs CDMO Services Product Offered 11.33.3 Societal CDMO Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.33.4 Societal CDMO Main Business Overview 11.33.5 Societal CDMO Latest Developments 11.34 MedPharm 11.34.1 MedPharm Company Information 11.34.2 MedPharm Small Molecule Drugs CDMO Services Product Offered 11.34.3 MedPharm Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.34.4 MedPharm Main Business Overview 11.34.5 MedPharm Latest Developments 11.35 Euroapi 11.35.1 Euroapi Company Information 11.35.2 Euroapi Small Molecule Drugs CDMO Services Product Offered 11.35.3 Euroapi Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.35.4 Euroapi Main Business Overview 11.35.5 Euroapi Latest Developments 11.36 BioVectra 11.36.1 BioVectra Company Information 11.36.2 BioVectra Small Molecule Drugs CDMO Services Product Offered 11.36.3 BioVectra Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.36.4 BioVectra Main Business Overview 11.36.5 BioVectra Latest Developments 11.37 Pfizer CentreOne 11.37.1 Pfizer CentreOne Company Information 11.37.2 Pfizer CentreOne Small Molecule Drugs CDMO Services Product Offered 11.37.3 Pfizer CentreOne Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.37.4 Pfizer CentreOne Main Business Overview 11.37.5 Pfizer CentreOne Latest Developments 11.38 Fermion 11.38.1 Fermion Company Information 11.38.2 Fermion Small Molecule Drugs CDMO Services Product Offered 11.38.3 Fermion Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.38.4 Fermion Main Business Overview 11.38.5 Fermion Latest Developments 11.39 Lundbeck 11.39.1 Lundbeck Company Information 11.39.2 Lundbeck Small Molecule Drugs CDMO Services Product Offered 11.39.3 Lundbeck Small Molecule Drugs CDMO Services Revenue, Gross Margin and Market Share (2021-2026) 11.39.4 Lundbeck Main Business Overview 11.39.5 Lundbeck Latest Developments 12 Research Findings and Conclusion List of Tables/GraphsList of TablesTable 1. Small Molecule Drugs CDMO Services Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions) Table 2. Small Molecule Drugs CDMO Services Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions) Table 3. Major Players of Molecular Drug Intermediates Table 4. Major Players of API Table 5. Major Players of Prepared Products Table 6. Small Molecule Drugs CDMO Services Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions) Table 7. Global Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 8. Global Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Table 9. Small Molecule Drugs CDMO Services Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions) Table 10. Global Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 11. Global Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Table 12. Global Small Molecule Drugs CDMO Services Revenue by Player (2021-2026) & ($ millions) Table 13. Global Small Molecule Drugs CDMO Services Revenue Market Share by Player (2021-2026) Table 14. Small Molecule Drugs CDMO Services Key Players Head office and Products Offered Table 15. Small Molecule Drugs CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2024-2026) Table 16. New Products and Potential Entrants Table 17. Mergers & Acquisitions, Expansion Table 18. Global Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) & ($ millions) Table 19. Global Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Table 20. Global Small Molecule Drugs CDMO Services Revenue by Country/Region (2021-2026) & ($ millions) Table 21. Global Small Molecule Drugs CDMO Services Revenue Market Share by Country/Region (2021-2026) Table 22. Americas Small Molecule Drugs CDMO Services Market Size by Country (2021-2026) & ($ millions) Table 23. Americas Small Molecule Drugs CDMO Services Market Size Market Share by Country (2021-2026) Table 24. Americas Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 25. Americas Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Table 26. Americas Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 27. Americas Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Table 28. APAC Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) & ($ millions) Table 29. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Table 30. APAC Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 31. APAC Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 32. Europe Small Molecule Drugs CDMO Services Market Size by Country (2021-2026) & ($ millions) Table 33. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Country (2021-2026) Table 34. Europe Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 35. Europe Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 36. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Region (2021-2026) & ($ millions) Table 37. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Type (2021-2026) & ($ millions) Table 38. Middle East & Africa Small Molecule Drugs CDMO Services Market Size by Application (2021-2026) & ($ millions) Table 39. Key Market Drivers & Growth Opportunities of Small Molecule Drugs CDMO Services Table 40. Key Market Challenges & Risks of Small Molecule Drugs CDMO Services Table 41. Key Industry Trends of Small Molecule Drugs CDMO Services Table 42. Global Small Molecule Drugs CDMO Services Market Size Forecast by Region (2027-2032) & ($ millions) Table 43. Global Small Molecule Drugs CDMO Services Market Size Market Share Forecast by Region (2027-2032) Table 44. Global Small Molecule Drugs CDMO Services Market Size Forecast by Type (2027-2032) & ($ millions) Table 45. Global Small Molecule Drugs CDMO Services Market Size Forecast by Application (2027-2032) & ($ millions) Table 46. Catalent Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 47. Catalent Small Molecule Drugs CDMO Services Product Offered Table 48. Catalent Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 49. Catalent Main Business Table 50. Catalent Latest Developments Table 51. Thermo Fisher Scientific Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 52. Thermo Fisher Scientific Small Molecule Drugs CDMO Services Product Offered Table 53. Thermo Fisher Scientific Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 54. Thermo Fisher Scientific Main Business Table 55. Thermo Fisher Scientific Latest Developments Table 56. Lonza Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 57. Lonza Small Molecule Drugs CDMO Services Product Offered Table 58. Lonza Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 59. Lonza Main Business Table 60. Lonza Latest Developments Table 61. Siegfried Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 62. Siegfried Small Molecule Drugs CDMO Services Product Offered Table 63. Siegfried Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 64. Siegfried Main Business Table 65. Siegfried Latest Developments Table 66. Recipharm Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 67. Recipharm Small Molecule Drugs CDMO Services Product Offered Table 68. Recipharm Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 69. Recipharm Main Business Table 70. Recipharm Latest Developments Table 71. Boehringer Ingelheim Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 72. Boehringer Ingelheim Small Molecule Drugs CDMO Services Product Offered Table 73. Boehringer Ingelheim Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 74. Boehringer Ingelheim Main Business Table 75. Boehringer Ingelheim Latest Developments Table 76. WuXi AppTech Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 77. WuXi AppTech Small Molecule Drugs CDMO Services Product Offered Table 78. WuXi AppTech Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 79. WuXi AppTech Main Business Table 80. WuXi AppTech Latest Developments Table 81. WuXi Biologics Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 82. WuXi Biologics Small Molecule Drugs CDMO Services Product Offered Table 83. WuXi Biologics Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 84. WuXi Biologics Main Business Table 85. WuXi Biologics Latest Developments Table 86. Fareva Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 87. Fareva Small Molecule Drugs CDMO Services Product Offered Table 88. Fareva Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 89. Fareva Main Business Table 90. Fareva Latest Developments Table 91. Samsung Biologics Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 92. Samsung Biologics Small Molecule Drugs CDMO Services Product Offered Table 93. Samsung Biologics Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 94. Samsung Biologics Main Business Table 95. Samsung Biologics Latest Developments Table 96. Aenova Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 97. Aenova Small Molecule Drugs CDMO Services Product Offered Table 98. Aenova Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 99. Aenova Main Business Table 100. Aenova Latest Developments Table 101. Delpharm Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 102. Delpharm Small Molecule Drugs CDMO Services Product Offered Table 103. Delpharm Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 104. Delpharm Main Business Table 105. Delpharm Latest Developments Table 106. Strides Pharma Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 107. Strides Pharma Small Molecule Drugs CDMO Services Product Offered Table 108. Strides Pharma Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 109. Strides Pharma Main Business Table 110. Strides Pharma Latest Developments Table 111. Piramal Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 112. Piramal Small Molecule Drugs CDMO Services Product Offered Table 113. Piramal Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 114. Piramal Main Business Table 115. Piramal Latest Developments Table 116. Famar Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 117. Famar Small Molecule Drugs CDMO Services Product Offered Table 118. Famar Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 119. Famar Main Business Table 120. Famar Latest Developments Table 121. Curia Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 122. Curia Small Molecule Drugs CDMO Services Product Offered Table 123. Curia Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 124. Curia Main Business Table 125. Curia Latest Developments Table 126. Jubilant Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 127. Jubilant Small Molecule Drugs CDMO Services Product Offered Table 128. Jubilant Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 129. Jubilant Main Business Table 130. Jubilant Latest Developments Table 131. Vetter Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 132. Vetter Small Molecule Drugs CDMO Services Product Offered Table 133. Vetter Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 134. Vetter Main Business Table 135. Vetter Latest Developments Table 136. AGC Pharma Chemicals Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 137. AGC Pharma Chemicals Small Molecule Drugs CDMO Services Product Offered Table 138. AGC Pharma Chemicals Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 139. AGC Pharma Chemicals Main Business Table 140. AGC Pharma Chemicals Latest Developments Table 141. Asymchem Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 142. Asymchem Small Molecule Drugs CDMO Services Product Offered Table 143. Asymchem Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 144. Asymchem Main Business Table 145. Asymchem Latest Developments Table 146. Porton Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 147. Porton Small Molecule Drugs CDMO Services Product Offered Table 148. Porton Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 149. Porton Main Business Table 150. Porton Latest Developments Table 151. Eurofins Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 152. Eurofins Small Molecule Drugs CDMO Services Product Offered Table 153. Eurofins Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 154. Eurofins Main Business Table 155. Eurofins Latest Developments Table 156. Ascendia Pharmaceuticals Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 157. Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Product Offered Table 158. Ascendia Pharmaceuticals Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 159. Ascendia Pharmaceuticals Main Business Table 160. Ascendia Pharmaceuticals Latest Developments Table 161. Ardena Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 162. Ardena Small Molecule Drugs CDMO Services Product Offered Table 163. Ardena Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 164. Ardena Main Business Table 165. Ardena Latest Developments Table 166. CPL Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 167. CPL Small Molecule Drugs CDMO Services Product Offered Table 168. CPL Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 169. CPL Main Business Table 170. CPL Latest Developments Table 171. UPM Pharmaceuticals Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 172. UPM Pharmaceuticals Small Molecule Drugs CDMO Services Product Offered Table 173. UPM Pharmaceuticals Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 174. UPM Pharmaceuticals Main Business Table 175. UPM Pharmaceuticals Latest Developments Table 176. FUJIFILM Diosynth Biotechnologies Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 177. FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Product Offered Table 178. FUJIFILM Diosynth Biotechnologies Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 179. FUJIFILM Diosynth Biotechnologies Main Business Table 180. FUJIFILM Diosynth Biotechnologies Latest Developments Table 181. Groupe Parima Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 182. Groupe Parima Small Molecule Drugs CDMO Services Product Offered Table 183. Groupe Parima Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 184. Groupe Parima Main Business Table 185. Groupe Parima Latest Developments Table 186. TBD Pharmatech Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 187. TBD Pharmatech Small Molecule Drugs CDMO Services Product Offered Table 188. TBD Pharmatech Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 189. TBD Pharmatech Main Business Table 190. TBD Pharmatech Latest Developments Table 191. Avid Bioservices Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 192. Avid Bioservices Small Molecule Drugs CDMO Services Product Offered Table 193. Avid Bioservices Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 194. Avid Bioservices Main Business Table 195. Avid Bioservices Latest Developments Table 196. NextPharma Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 197. NextPharma Small Molecule Drugs CDMO Services Product Offered Table 198. NextPharma Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 199. NextPharma Main Business Table 200. NextPharma Latest Developments Table 201. Alcami Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 202. Alcami Small Molecule Drugs CDMO Services Product Offered Table 203. Alcami Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 204. Alcami Main Business Table 205. Alcami Latest Developments Table 206. Societal CDMO Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 207. Societal CDMO Small Molecule Drugs CDMO Services Product Offered Table 208. Societal CDMO Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 209. Societal CDMO Main Business Table 210. Societal CDMO Latest Developments Table 211. MedPharm Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 212. MedPharm Small Molecule Drugs CDMO Services Product Offered Table 213. MedPharm Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 214. MedPharm Main Business Table 215. MedPharm Latest Developments Table 216. Euroapi Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 217. Euroapi Small Molecule Drugs CDMO Services Product Offered Table 218. Euroapi Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 219. Euroapi Main Business Table 220. Euroapi Latest Developments Table 221. BioVectra Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 222. BioVectra Small Molecule Drugs CDMO Services Product Offered Table 223. BioVectra Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 224. BioVectra Main Business Table 225. BioVectra Latest Developments Table 226. Pfizer CentreOne Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 227. Pfizer CentreOne Small Molecule Drugs CDMO Services Product Offered Table 228. Pfizer CentreOne Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 229. Pfizer CentreOne Main Business Table 230. Pfizer CentreOne Latest Developments Table 231. Fermion Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 232. Fermion Small Molecule Drugs CDMO Services Product Offered Table 233. Fermion Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 234. Fermion Main Business Table 235. Fermion Latest Developments Table 236. Lundbeck Details, Company Type, Small Molecule Drugs CDMO Services Area Served and Its Competitors Table 237. Lundbeck Small Molecule Drugs CDMO Services Product Offered Table 238. Lundbeck Small Molecule Drugs CDMO Services Revenue ($ million), Gross Margin and Market Share (2021-2026) Table 239. Lundbeck Main Business Table 240. Lundbeck Latest Developments List of Figures Figure 1. Small Molecule Drugs CDMO Services Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Small Molecule Drugs CDMO Services Market Size Growth Rate (2021-2032) ($ millions) Figure 6. Small Molecule Drugs CDMO Services Sales by Geographic Region (2021, 2025 & 2032) & ($ millions) Figure 7. Small Molecule Drugs CDMO Services Sales Market Share by Country/Region (2025) Figure 8. Small Molecule Drugs CDMO Services Sales Market Share by Country/Region (2021, 2025 & 2032) Figure 9. Global Small Molecule Drugs CDMO Services Market Size Market Share by Type in 2025 Figure 10. Small Molecule Drugs CDMO Services in Clinical Figure 11. Global Small Molecule Drugs CDMO Services Market: Clinical (2021-2026) & ($ millions) Figure 12. Small Molecule Drugs CDMO Services in Commercial Figure 13. Global Small Molecule Drugs CDMO Services Market: Commercial (2021-2026) & ($ millions) Figure 14. Global Small Molecule Drugs CDMO Services Market Size Market Share by Application in 2025 Figure 15. Global Small Molecule Drugs CDMO Services Revenue Market Share by Player in 2025 Figure 16. Global Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Figure 17. Americas Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 18. APAC Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 19. Europe Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 20. Middle East & Africa Small Molecule Drugs CDMO Services Market Size 2021-2026 ($ millions) Figure 21. Americas Small Molecule Drugs CDMO Services Value Market Share by Country in 2025 Figure 22. United States Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 23. Canada Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 24. Mexico Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 25. Brazil Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 26. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Region in 2025 Figure 27. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Figure 28. APAC Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Figure 29. China Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 30. Japan Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 31. South Korea Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 32. Southeast Asia Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 33. India Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 34. Australia Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 35. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Country in 2025 Figure 36. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Figure 37. Europe Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Figure 38. Germany Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 39. France Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 40. UK Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 41. Italy Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 42. Russia Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 43. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Market Share by Region (2021-2026) Figure 44. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Market Share by Type (2021-2026) Figure 45. Middle East & Africa Small Molecule Drugs CDMO Services Market Size Market Share by Application (2021-2026) Figure 46. Egypt Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 47. South Africa Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 48. Israel Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 49. Turkey Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 50. GCC Countries Small Molecule Drugs CDMO Services Market Size Growth 2021-2026 ($ millions) Figure 51. Americas Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 52. APAC Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 53. Europe Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 54. Middle East & Africa Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 55. United States Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 56. Canada Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 57. Mexico Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 58. Brazil Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 59. China Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 60. Japan Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 61. Korea Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 62. Southeast Asia Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 63. India Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 64. Australia Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 65. Germany Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 66. France Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 67. UK Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 68. Italy Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 69. Russia Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 70. Egypt Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 71. South Africa Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 72. Israel Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 73. Turkey Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions) Figure 74. Global Small Molecule Drugs CDMO Services Market Size Market Share Forecast by Type (2027-2032) Figure 75. Global Small Molecule Drugs CDMO Services Market Size Market Share Forecast by Application (2027-2032) Figure 76. GCC Countries Small Molecule Drugs CDMO Services Market Size 2027-2032 ($ millions)
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野（医療）の最新刊レポート
LP Information社の 医療分野 での最新刊レポート
よくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
|
